OPEN’s review of MedsCheck Diabetes program in Ontario
Thursday, April 6, 2017, Toronto, ON — More than 2 million Canadians currently live with diabetes, costing the healthcare system $13.1 billion a year. It is the leading cause of adult onset blindness, kidney disease, and non-traumatic lower limb amputations, and diabetes patients are two to four times more likely to die of cardiovascular disease than those without diabetes.
In 2010, the Ontario Ministry of Health and Long-Term Care introduced the MedsCheck Diabetes program to help patients better understand their medication therapy and ensure their medications are taken as prescribed. Conducted by community pharmacists, these annual medication reviews promote healthier patient outcomes and self-management of the disease, improve and optimize drug therapy and lifestyle, and ensure the safe, effective and appropriate use of all types of medications, medication devices and supplies.
Researchers from the University of Toronto, McMaster University and the Ontario Pharmacy Evidence Network have published the findings of a four-year review of the MedsCheck Diabetes program in the Canadian Journal of Diabetes.
Recognizing that medications play a vital role in reducing the development and progression of diabetes complications, the researchers were interested to see if the MedsCheck Diabetes program was accessed by patients, develop a composite of who those patients are, and determine whether they took advantage of it annually.
Using administrative claims data for Ontario held by the Institute for Clinical Evaluative Sciences, they discovered that roughly half of Ontarians with diabetes received a MedsCheck Diabetes review between 2010 and 2014. However, only 4.1% of recipients 66 years of age or older and 2.7% of recipients younger than 66 years of age received a MedsCheck Diabetes follow-up over the same period.
“Through our analysis, it was encouraging to confirm that almost half of Ontarians with diabetes had received this specialized pharmacist consultation, indicating that pharmacists are ready to deliver this type of care to diabetes patients. One surprising finding, however, was that we observed a very low number of follow-up visits despite this being part of the original program,” noted Dr. Lori MacCallum, Sun Life Financial Professor of Wellness and Diabetes Education at the Banting & Best Diabetes Centre and Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto, lead author of the paper.
“This is concerning given the chronic nature of diabetes and the complexity of patients receiving the annual review. One would think that follow-up visits would be necessary and desired to ensure continuity of quality care.”
The study revealed a great deal about the patients that are accessing this service, including that recipients 66 years of age and older were on an average of 11 different medications over a one-year period before they received a MedsCheck Diabetes review, many of which were high-risk medications like blood thinners, benzodiazepines and narcotics that are known to cause significant adverse effects in the elderly. In addition, over one-third of MedsCheck Diabetes recipients (33.5%) had a diabetes-related emergency room visit or hospitalization in the year prior to their MedsCheck Diabetes review.
“This study provides a solid foundation for understanding how MedsCheck Diabetes reviews have been utilized since their introduction,” said Dr. MacCallum. “Now, however, we need to continue this research to understand the benefit they provide to patients and the healthcare system, and discover what the enablers and impediments are that influence how this service is offered by pharmacists and accessed by patients.”
This study was funded by a grant from the Ministry of Health and Long-Term Care through the Ontario Pharmacy Evidence Network.
Read an article by Lu-Ann Murdoch about the results from the study (PDF), published in CanadianHealthcareNetwork.ca on April 11, 2017.
Dr. Lori MacCallum
Sun Life Financial Professor of Wellness and Diabetes Education
Banting & Best Diabetes Centre
Faculty of Medicine
Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto
(416) 340-4800, extension 2784
OPEN: Ontario Pharmacy Evidence Network
School of Pharmacy
University of Waterloo - Health Sciences Campus
10A Victoria St. S, Kitchener, ON N2G 1C5
Leslie Dan Faculty of Pharmacy
University of Toronto – St-George Campus
144 College St, Toronto, ON M5S 3M2
Sign up to receive monthly updates
Copyright © 2021 Ontario Pharmacy Evidence Network
Designed + Developed by Code Blocks